Daniela Lulli Selected Research

Daniela Lulli Research Topics

5	Carcinogenesis 03/2023 - 01/2013
5	Neoplasms (Cancer) 01/2023 - 11/2012
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 05/2011
3	Inflammation (Inflammations) 01/2022 - 08/2011
1	Melanoma (Melanoma, Malignant) 01/2023
1	Vitiligo 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Edema (Dropsy) 09/2018
1	Contact Dermatitis (Eczema, Contact) 09/2018
1	Sarcoma (Soft Tissue Sarcoma) 10/2017
1	Wounds and Injuries (Trauma) 02/2012
1	Necrosis 08/2009

4	ResveratrolIBA 09/2018 - 02/2012
4	PolyphenolsIBA 09/2018 - 08/2009
3	Interferon Type IIBA 09/2018 - 07/2016
3	ErbB Receptors (EGF Receptor)IBA 10/2017 - 06/2014
3	AntioxidantsIBA 02/2012 - 08/2009
2	QuercetinIBA 09/2018 - 02/2012
2	ChemokinesIBA 02/2012 - 08/2009
1	ceric oxide (cerium dioxide)IBA 03/2023
1	AntibodiesIBA 01/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023
1	Interleukin-17 (Interleukin 17)IBA 01/2023
1	Apoptosis Regulatory ProteinsIBA 01/2023
1	NucleophosminIBA 01/2022
1	NF-kappa B (NF-kB)IBA 01/2022
1	Insulin-Like Growth Factor Binding Protein 2IBA 01/2020
1	Cetuximab (Erbitux)FDA Link 09/2018
1	DinitrofluorobenzeneIBA 09/2018
1	Gefitinib (Iressa)FDA Link 09/2018
1	HaptensIBA 09/2018
1	cobimetinibIBA 10/2017
1	dabrafenibIBA 10/2017
1	VemurafenibIBA 10/2017
1	trametinibIBA 10/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2017
1	Humanized Monoclonal AntibodiesIBA 07/2016
1	LigandsIBA 06/2014
1	Superoxides (Superoxide)IBA 02/2012
1	polydatinIBA 02/2012
1	Rutin (Rutoside)IBA 02/2012
1	acteosideIBA 02/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2011
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2011
1	Recombinant ProteinsIBA 05/2011
1	efalizumab (Raptiva)FDA Link 05/2011
1	CytokinesIBA 05/2011
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 05/2011
1	EnzymesIBA 05/2011

2	Therapeutics 01/2023 - 05/2011
1	Immunotherapy 01/2023